 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
|
|
|
|
Phase III, Phase II
|
|
|
|
EUDRACT 2005-002618-40
BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723
|
|
| |
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
|
|
|
|
Phase III
|
|
|
|
COG-ACNS0331
ACNS0331, NCT00085735
|
|
| |
Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
|
|
|
|
Phase III
|
|
|
|
SJCRH-SJMB03
NCT00085202
|
|
| |
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
|
|
|
|
Phase III
|
|
|
|
GPOH-HIT-GBM-D
EU-205100, NCT00278278
|
|
| |
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
|
|
|
|
Phase III
|
|
|
|
COG-ACNS0334
ACNS0334, NCT00336024
|
|
| |
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
|
|
|
|
Phase III
|
|
|
|
CHLA-HEAD-START-III
CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
|
|
| |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
|
|
|
|
Phase III
|
|
|
|
COG-ACNS0332
ACNS0332, NCT00392327
|
|
| |
Treatment of Tumors of the Choroid Plexus Epithelium
|
|
|
|
Phase III
|
|
|
|
2005-0398
NCT00500890
|
|
| |
SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours
|
|
|
|
Phase III
|
|
|
|
SCRT Trial
NCT00517959
|
|
| |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, or Osteosarcoma
|
|
|
|
Phase III
|
|
|
|
COG-ACCL0431
ACCL0431, NCT00716976
|
|
